Cargando…
PMON91 Late Presentation of Pituitary Apoplexy Following Gonadotropin-Releasing Hormone Agonist for Prostate Cancer Treatment
BACKGROUND: Pituitary apoplexy (PA) is characterized by sudden increase in pituitary gland volume secondary to ischemia and/or necrosis. Certain predisposing factors can result in PA and use of gonadotropin-releasing hormone (GnRH) agonist for prostate cancer (PCa) is one such condition. We present...
Autores principales: | Raj, Rishi, Elshimy, Ghada, Owen, Douglas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625137/ http://dx.doi.org/10.1210/jendso/bvac150.1183 |
Ejemplares similares
-
Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy
por: Yu, Xiaoling, et al.
Publicado: (2021) -
PMON112 Primary Pituitary Lymphoma Presenting as Apoplexy
por: Abdelaziz, Sara, et al.
Publicado: (2022) -
MON-239 Pituitary Apoplexy Induced by Gonadotropin-Releasing Hormone Agonist Administration: A Rare Complication of Prostate Cancer Treatment
por: Barbosa, Mariana Marques, et al.
Publicado: (2020) -
PMON130 Pituitary apoplexy presenting as left basal ganglia hemorrhage
por: Zahid, Maleeha, et al.
Publicado: (2022) -
FRI336 A Case Of Pituitary Apoplexy In Late Pregnancy
por: Abdelrahman, Houda, et al.
Publicado: (2023)